摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tributyl-(6-chloro-3-methoxy-pyridazin-4-yl)stannane | 404933-40-0

中文名称
——
中文别名
——
英文名称
tributyl-(6-chloro-3-methoxy-pyridazin-4-yl)stannane
英文别名
Tributyl-(6-chloro-3-methoxypyridazin-4-yl)stannane;tributyl-(6-chloro-3-methoxypyridazin-4-yl)stannane
tributyl-(6-chloro-3-methoxy-pyridazin-4-yl)stannane化学式
CAS
404933-40-0
化学式
C17H31ClN2OSn
mdl
——
分子量
433.609
InChiKey
BNRRIFBMRSRBEZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.19
  • 重原子数:
    22
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.76
  • 拓扑面积:
    35
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    tributyl-(6-chloro-3-methoxy-pyridazin-4-yl)stannane盐酸copper(l) iodide四(三苯基膦)钯1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 sodium carbonate 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 1,4-二氧六环5,5-dimethyl-1,3-cyclohexadiene二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 29.0h, 生成 (2S,4R)-4-hydroxy-1-((S)-2-(2-(4-(4-(6-(2-hydroxyphenyl)-3-methoxypyridazin-4-yl)phenyl)piperazin-1-yl)acetamido)-3,3-dimethylbutanoyl)-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
    参考文献:
    名称:
    [EN] 3-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS
    [FR] COMPOSÉS PYRIDAZINE 3-SUBSTITUÉS UTILISÉS EN TANT QU'AGENTS DE DÉGRADATION DE SMARCA2 ET/OU DE SMARCA4
    摘要:
    The present invention provides 3-substituted pyridazine compound of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
    公开号:
    WO2023152666A1
  • 作为产物:
    参考文献:
    名称:
    Pyridazinones and triazinones and medicinal use thereof
    摘要:
    本发明提供了一种在AMPA受体和/或翘曲酸受体上表现出优异的抑制作用的新型化合物。也就是说,它提供了以下公式所代表的化合物、其盐或其水合物。在该公式中,A1、A2和A3彼此独立,每个代表一个C3-8环烷基、一个C3-8环烯基、一个5-至14-成员非芳香杂环基、一个C6-14芳香烃环基或一个5-至14-成员芳香杂环基,每个都可以被取代;Q代表O、S或NH;Z代表C或N;X1、X2和X3彼此独立,每个代表一个单键,一个可选择取代的C1-6烷基基团,一个可选择取代的C2-6烯基基团,一个可选择取代的C2-6炔基基团,—NH—、—O—、—NHCO—、—CONH—、—SO0-2等;R1和R2彼此独立,每个代表一个氢原子或一个可选择取代的C1-6烷基基团,或者R1和R2可以结合在一起,使得CR2-ZR1形成C═C;和R3代表一个氢原子或一个可选择取代的C1-6烷基基团等,或者可以与A1或A3中的任何原子结合,与该原子一起形成一个可选择取代的C5-8碳氢环或一个可选择取代的5-至8-成员杂环环。
    公开号:
    US20030225081A1
点击查看最新优质反应信息

文献信息

  • [EN] HERBICIDAL COMPOUNDS<br/>[FR] COMPOSÉS HERBICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2019034757A1
    公开(公告)日:2019-02-21
    Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.
    式(I)中的化合物,其中取代基如权利要求1中定义的那样,作为杀虫剂特别是除草剂是有用的。
  • [EN] PRE-HARVEST DESICCATION METHOD<br/>[FR] PROCÉDÉ DE DESSICCATION PRÉ-RÉCOLTE
    申请人:SYNGENTA CROP PROTECTION AG
    公开号:WO2020164971A1
    公开(公告)日:2020-08-20
    A method for the pre-harvest desiccation of crop plants which comprises applying to the crop plants an effective amount of a compound of formula (I) or an agronomically acceptable salt or zwitterionic species thereof, wherein the substituents are as defined in claim 1.
    一种用于作物植物成熟前脱水的方法,包括向作物植物施加化合物(I)的有效量或其农学上可接受的盐或带电中性物种,其中取代基如权利要求1所定义。
  • Pyridazinones and triazinones and medicinal use thereof
    申请人:——
    公开号:US20030225081A1
    公开(公告)日:2003-12-04
    The present invention provides a novel compound exhibiting an excellent inhibitory action on AMPA receptor and/or kainate receptor. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. 1 In the formula, A 1 , A 2 and A 3 are independent of each other and each represents a C 3-8 cycloalkyl group, a C 3-8 cycloalkenyl group, a 5- to 14-membered non-aromatic heterocyclic group, a C 6-14 aromatic hydrocarbon cyclic group or a 5- to 14-membered aromatic heterocyclic group, each of which may be substituted; Q represents O, S or NH; Z represents C or N; X 1 , X 2 and X 3 are independent of each other and each represents a single bond, an optionally substituted C 1-6 alkylene group, an optionally substituted C 2-6 alkenylene group, an optionally substituted C 2-6 alkynylene group, —NH—, —O—, —NHCO—, —CONH—, —SO 0-2 , etc.; R 1 and R 2 are independent of each other and each represents a hydrogen atom or an optionally substituted C 1-6 alkyl group, or R 1 and R 2 may be bound together such that CR 2 -ZR 1 forms C═C; and R 3 represents a hydrogen atom or an optionally substituted C 1-6 alkyl group etc., or may be bound to any atom in A 1 or A 3 to form, together with the atom, an optionally substituted C 5-8 hydrocarbon ring or an optionally substituted 5- to 8-membered heterocyclic ring.
    本发明提供了一种在AMPA受体和/或翘曲酸受体上表现出优异的抑制作用的新型化合物。也就是说,它提供了以下公式所代表的化合物、其盐或其水合物。在该公式中,A1、A2和A3彼此独立,每个代表一个C3-8环烷基、一个C3-8环烯基、一个5-至14-成员非芳香杂环基、一个C6-14芳香烃环基或一个5-至14-成员芳香杂环基,每个都可以被取代;Q代表O、S或NH;Z代表C或N;X1、X2和X3彼此独立,每个代表一个单键,一个可选择取代的C1-6烷基基团,一个可选择取代的C2-6烯基基团,一个可选择取代的C2-6炔基基团,—NH—、—O—、—NHCO—、—CONH—、—SO0-2等;R1和R2彼此独立,每个代表一个氢原子或一个可选择取代的C1-6烷基基团,或者R1和R2可以结合在一起,使得CR2-ZR1形成C═C;和R3代表一个氢原子或一个可选择取代的C1-6烷基基团等,或者可以与A1或A3中的任何原子结合,与该原子一起形成一个可选择取代的C5-8碳氢环或一个可选择取代的5-至8-成员杂环环。
  • [EN] 3-SUBSTITUTED PYRIDAZINE COMPOUNDS AS SMARCA2 AND/OR SMARCA4 DEGRADERS<br/>[FR] COMPOSÉS PYRIDAZINE 3-SUBSTITUÉS UTILISÉS EN TANT QU'AGENTS DE DÉGRADATION DE SMARCA2 ET/OU DE SMARCA4
    申请人:[en]AURIGENE ONCOLOGY LIMITED
    公开号:WO2023152666A1
    公开(公告)日:2023-08-17
    The present invention provides 3-substituted pyridazine compound of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or prevention of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt or a stereoisomer or a tautomer thereof.
查看更多